PDS Biotechnology Earnings Preview
Portfolio Pulse from Benzinga Insights
PDS Biotechnology (NASDAQ:PDSB) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $4.795 as of August 10, with a 52-week period showing a 17.7% decrease.
August 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
PDS Biotechnology is expected to report an EPS of $-0.37 in its upcoming earnings report. Past earnings reports have influenced the company's share price, which currently stands at $4.795, marking a 17.7% decrease over the last 52 weeks.
The upcoming earnings report is highly relevant to PDS Biotechnology's stock price, as past earnings reports have shown a pattern of influencing the share price. Given the estimated EPS of $-0.37 and the company's recent negative performance, the short-term impact on the stock price is likely to be negative.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100